Search

everythinglearnresearchcommunity

for

Search:↓

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Targeting colon cancer stem cells might lead to better treatment results.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

p120-catenin helps control skin inflammation by regulating cadherin levels.

Effective management of side effects is crucial for safe use of sacituzumab govitecan in advanced breast cancer treatment.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Hair repigmentation can indicate malignancy and should be investigated.

RCS-01 therapy is safe and may improve skin structure by affecting gene expression.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.

Activating β-catenin in certain skin cells speeds up hair growth in mice.

Cardiomyocyte-derived media can inhibit lung cancer cell growth and movement.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Different types of skin gland tumors have unique genetic traits, which can guide personalized treatments.

miR-200c-3p could help diagnose and treat alopecia areata.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

The method effectively predicts new drug uses, including potential COVID-19 treatments.

Proinflammatory fibroblasts and vascular endothelial cells are key in keloid development.

Deucravacitinib helped a man regrow hair and improve psoriasis.

IL-9/IL-9R signaling can negatively affect human hair growth and may be a target for treating hair loss conditions.

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

Deleting the MAD2L1 gene is tolerated in certain mouse cancer models.

A woman had a rare skin condition with recurring painful nodules that heal in 6 weeks, often without needing treatment.

CD25+ CD4+ Tregs and certain plasma proteins are linked to hair loss.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

IL-18 signaling helps mature Tregs move into the thymus.

Raman micro-spectroscopy can help distinguish basal cell carcinoma from hair follicles in skin tissue.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

New insights into cell communication in psoriasis suggest innovative drug treatments.